U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX2069626: GSM2299180: 6d_cKO2; Mus musculus; RNA-Seq
1 ILLUMINA (Illumina HiSeq 2500) run: 43.9M spots, 2.2G bases, 1.3Gb downloads

Submitted by: NCBI (GEO)
Study: Transcriptional Maintenance of Pancreatic Acinar Identity, Differentiation and Homeostasis by PTF1A [6-day RNA-Seq]
show Abstracthide Abstract
RNA-seq analysis documented mRNA changes in total pancreatic RNA preparations 6 days after Ptf1a inactivation. Overall design: pancreas mRNA profiles of Tamoxifen treated adult control mice [Ptf1a(CreER/+)] and Ptf1a conditional knockout mice [Ptf1a(CreER/fl)] were generated by deep sequencing using an Illumina Hiseq 2500.
Sample: 6d_cKO2
SAMN05717692 • SRS1660338 • All experiments • All runs
Organism: Mus musculus
Library:
Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: RNA preparation: pancreas was homogenized in 4 M Guanidine Thiocyanate, 0.1 M Tris HCl pH 7.5, 1% 2-mercaptoethanol with a Tekmar Tissuemizer. RNA was isolated from an aliquot of the homogenate by addition of N-Lauroylsarcosine sodium salt to 0.5%, Potassium Acetate pH 5.5 to 0.1 M, and Acetic Acid to 0.08 M, followed by addition of 0.75 volume ethanol while vortexing. RNA was allowed to precipitate from the solution at -20 C for at least 1 hour, collected by centrifugation at 12,000 g for 5', and the RNA pellet resuspended in Trizol (equal volume to starting homogenate). Subsequent steps were as per manufacturer's protocol (Life Technologies). RNA libraries were prepared for sequencing using standard Illumina True-seq protocols
Experiment attributes:
GEO Accession: GSM2299180
Links:
Runs: 1 run, 43.9M spots, 2.2G bases, 1.3Gb
Run# of Spots# of BasesSizePublished
SRR410351843,905,3932.2G1.3Gb2016-09-05

ID:
3063879

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...